Visual & Quantitative Assessment Amyloid-PET: the era of disease-modifying therapies for Alzheimer

In this webinar, we will explore the evolving role of amyloid-PET imaging in the diagnosis and management of Alzheimer’s disease, particularly in the context of the arrival of disease-modifying therapies. The session will begin with a brief introduction, followed by an expert overview of the current landscape of amyloid-PET interpretation by Prof. Mathías Brendel. Then, Dr. Pedro Plaza will present real-world clinical cases where Neurocloud, Qubiotech’s AI-powered platform, has supported both visual and quantitative assessments, including the application of the Centiloid scale in routine clinical settings. The session ends with an open Q&A to address participants’ questions.